Ref ID: 18413
Author:
Michael Buess, Gieri Cathomas, Jörg Halter, Lilian Junker,
Peter Grendelmeier, Michael Tamm, Daiana Stolz
Author address:
Clinic for Pulmonary
Medicine and Respiratory Cell Research, University Hospital Basel, Basel,
Switzerland; Department of Microbiology, Kanton Hospital Liestal, Liestal,
Switzerland; Clinic for Hematology, University Hospital Basel, Basel,
Switze
Full conference title:
European Respiratory Congress
Abstract:
Introduction: Invasive fungal disease (IFD) is a frequent and serious infectious
complication in neutropenic patients. We evaluated the diagnostic accuracy of
conventional nested PCR in the bronchoalveolar fluid to diagnose IFD in severe
immunocompromised patients.
Methods: 191 consecutive patients undergoing bronchoscopy for suspected pulmonary
infection were included. The probability of IFD was estimated according
to the standard EORTC/NIAID classification and on clinical grounds as independently
assessed by a pulmonary specialist and hematologist. Conventional nested
PCR to detect aspergillus fumigatus, flavus, niger, glaucus, terreus and tomarrii
were applied to 2 ml bronchoalveolar fluid.
Results: Mean age was 50.5 y (19-80), 116 were male. There were 129 patients
with hematological conditions, 26 solid organ transplant recipients, 24 autoimmune
disorders, and 12 HIV. A total of 111 (58.1%) of the patients were on
anti-fungal therapy at the time of bronchoscopy. According to the EORTC/NIAID
classification, 2 (1%) had proven, 8 (4.2%) probable, 43 (22.5%) possible and 138
(72.3%) no IFD. Nested PCR for Aspergillus was positive in 55 cases (28.8%) –
0/2 in proven, 4/8 in probable, 10/43 in possible and 41/138 in no IFD. Anti-fungal
therapy did not significantly influenced PCR results (p=0.749). Irrespective of the
EORT/NIAID criteria, there was a strong clinical suspicion of IFD in 53 (27.7%)
cases. From those, only 15 (28.3%) had a positive nested PCR.
Conclusion: Conventional nested aspergillus PCR in the bronchoalveolar lavage
seems to be of limited usefulness for detection of invasive fungal disease in
immunocompromised patients.
Abstract Number: P2518
Conference Year: 2011
Link to conference website: http://www.ers-education.org/ersMade/abstract_print_11/files/Abstract_book_2011.pdf
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a